Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arrowhead Pharmaceuticals

15.74
-0.4800-2.96%
Post-market: 15.52-0.2231-1.42%19:10 EDT
Volume:1.22M
Turnover:19.22M
Market Cap:2.17B
PE:-13.85
High:16.11
Open:15.62
Low:15.54
Close:16.22
Loading ...

Arrowhead Pharmaceuticals Price Target Maintained With a $42.00/Share by RBC Capital

Dow Jones
·
12 Feb

Stock Track | Arrowhead Pharmaceuticals Plunges Over 8% in Pre-market Trading as Disappointing Q1 Earnings Weigh on Stock

Stock Track
·
11 Feb

Stock Track | Arrowhead Pharmaceuticals Plunges 6.63% in Pre-market Trading as Earnings Disappoint Investors

Stock Track
·
11 Feb

Arrowhead Pharmaceuticals: Promising Pipeline and Strategic Developments Drive Buy Rating

TIPRANKS
·
11 Feb

Arrowhead Pharmaceuticals Inc (ARWR) Q1 2025 Earnings Call Highlights: Strategic Collaborations ...

GuruFocus.com
·
11 Feb

Arrowhead Pharmaceuticals Reports Q1 2025 Financial Results

TIPRANKS
·
11 Feb

Arrowhead Pharmaceuticals: Strategic Licensing Deal and Upcoming Drug Launch Drive Buy Rating

TIPRANKS
·
11 Feb

Arrowhead Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
11 Feb

Arrowhead Pharmaceuticals Fiscal Q1 Loss Widens, Revenue Declines -- Shares Down After Hours

MT Newswires Live
·
11 Feb

Arrowhead Pharma Q1 2025 GAAP EPS $(1.39) Misses $(0.63) Estimate, Sales $2.50M Miss $65.47M Estimate

Benzinga
·
11 Feb

Arrowhead Research: Fiscal Q1 Earnings Snapshot

Associated Press Finance
·
11 Feb

Arrowhead reports Q1 EPS ($1.39), consensus (72c)

TIPRANKS
·
11 Feb

Arrowhead Closes Licensing, Collaboration Agreement With Sarepta

MT Newswires Live
·
10 Feb

Arrowhead to receives $500M upfront in licensing pact with Sarepta

TIPRANKS
·
10 Feb

Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement With Sarepta Therapeutics

THOMSON REUTERS
·
10 Feb

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
07 Feb

Genelux Names Matthew Pulisic as CFO

MT Newswires Live
·
03 Feb

Genelux Brings in Arrowhead Pharmaceuticals Exec as New Finance Chief

Dow Jones
·
03 Feb

Arrowhead Pharmaceuticals Price Target Maintained With a $80.00/Share by HC Wainwright & Co.

Dow Jones
·
23 Jan

BRIEF-S&P Dow Jones Indices Says Arrowhead Pharmaceuticals Will Replace Barnes Group Inc. In S&P Smallcap 600

Reuters
·
23 Jan